Inability of Probiotic Bacterial Strains Lactobadilus rhamnosus HN001 and Bifidobacterium lactis HN019 To Induce Human Platelet Aggregation In Vitro

Zhou, J. S.; Rutherfurd, K. J.; Gill, H. S.
November 2005
Journal of Food Protection;Nov2005, Vol. 68 Issue 11, p2459
Academic Journal
Platelet aggregation contributes to the pathogenesis of infective endocarditis, and aggregation of platelets induced by lactobacilli is thought to be an important contributory factor in the development and progression of Lactobacillus endocarditis. The main purpose of this study was to examine the effect of immunity-enhancing probiotic strains Lactobacillus rhamnosus HN001 and Bifidobacterium lactis HN019 on the activation and aggregation of human blood platelets. Whole blood samples from healthy individuals were incubated in vitro with HN001 or HN019 and subsequently labeled with platelet-specific monoclonal antibodies, fluorescein isothiocyanate-conjugated anti-CD41 a (expressed on normal platelets), and phycoerythrin-streptavidin-conjugated anti-CD62p (expressed on activated platelets) before analysis by flow cytometry. Platelet-rich plasma was used to assist the gating of the platelet cluster. ADP and epinephrine were used as the physiological platelet activation agonists. Platelet aggregation-inducing strain Streptococcus sanguis 133-79 was used as a positive control strain. The mean fluorescence intensity of phycoerythrin and the percentage of platelets expressing the CD62p marker were used to assess the degree of platelet activation. The percentage of CD62p-positive platelets and the light scatter profiles of the agonist-activated platelets were used to identify the occurrence and degree of platelet aggregation. HNOOI and HN019 had no effect on spontaneous platelet activation and aggregation; they also failed to exacerbate the platelet aggregation activity induced by ADP and epinephrine. Therefore, these test probiotic strains HN001 and HN019 are less likely to participate in the pathogenesis of infective endocarditis or other thrombotic disorders with regard to platelet aggregation factors.


Related Articles

  • aggregation, platelet. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p23 

    An encyclopedia entry for "platelet aggregation" is presented. It refers to the grouping of platelets that occurs when a blood vessel is damaged. It noted that platelet aggregation is the first step of blood clotting, helping close injured vessels. Drugs that help lessen platelet aggregation...

  • Platelet Aggregation and Exogenous Factors From Animal Sources. Kini, R. Manjunatha // Current Drug Targets - Cardiovascular & Haematological Disorders;Dec2004, Vol. 4 Issue 4, p301 

    Platelet aggregation plays a crucial role in thrombosis. This review describes exogenous factors isolated from various animal sources, including venoms and the salivary glands that interfere in platelet aggregation. Some of these factors induce platelet aggregation or agglutination, whereas...

  • Ten Years' Experience with the "Sticky Platelet Syndrome" Mammen, Eberhard F. // Clinical & Applied Thrombosis/Hemostasis;Winter1995, Vol. 1 Issue 1, p66 

    We describe a 10-year experience with a congenital platelet abnormality characterized by hyperaggregability with ADP and/or epinephrine. The syndrome has so far been identified in > 200 patients and their families. Clinical symptoms are transient or permanent arterial occlusions, thrombotic in...

  • Effect Of Intravenous Infusion Of Propofol On Platelet Function During ENT Procedures For Endoscopic Carbon Dioxide Laser, Septoplasty And Endoscopic Nasal Surgery. SAID, KASSIM M // Internet Journal of Otorhinolaryngology;2002, Vol. 1 Issue 1, p15 

    Propofol has inhibitory effect on platelet aggregation by using high dose more than9mg/kg.bw./hour.Also reduce the platelets count during surgery after 30 minutes from start. But has insignificant effect on bleeding time.It was happend in 3%of our cases,using propofol and 10% of cases using more...

  • A new stilbene glycoside from the n-butanol fraction of Veratrum dahuricum. Li-Min Dai; Jian Tang; Hui-Liang Li; Yun-Heng Shen; Cai-Yun Peng; Wei-Dong Zhang // Chemistry of Natural Compounds;May2009, Vol. 45 Issue 3, p325 

    A new stilbene glycoside, 5-methylresveratrol-3,4′- O- β-D-diglucopyranoside ( 1), was isolated from the n-butanol fraction of the rhizomes of Veratrum dahuricum, together with five known stilbenoids: resveratrol-3- O- β-D-glycoside ( 2), 4′-methylresveratrol-3- O-...

  • Evaluation of Whole-Blood Lumiaggregation. Podczasy, John J.; Lee, James; Vucenik, Ivana // Clinical & Applied Thrombosis/Hemostasis;Jul1997, Vol. 3 Issue 3, p190 

    An evaluation of whole-blood Unappreciation was conducted in a normal population. Platelet aggregation and adenosine triphosphate (ATP) secretion were monitored in a three-phase study that analyzed sample dilution, agonist dose response, and method comparison. In the first phase, the...

  • Modified Technique for Measuring Platelet Aggregation. Kaplan, Alexander; Kaplan, Svetlana; Marcoe, Karen F.; Sauvage, Lester R.; Hammond, William P. // Clinical & Applied Thrombosis/Hemostasis;Jul1997, Vol. 3 Issue 3, p196 

    The turbidimetric method of Born is the current approach for assessing the aggregation behavior of platelets. It has been of modest practical value, due to difficulty in standardizing laboratory techniques for plasma preparation and inadequate quantification of the aggregation process. We report...

  • PAF.  // Taber's Cyclopedic Medical Dictionary;2005, p1566 

    A definition of the medical term "PAF" is presented, which is defined as platelet aggregating factor. The definition is from the "Taber's Cyclopedic Medical Dictionary," published by F.A. Davis Co.

  • Identification of the platelet ADP receptor targeted by antithrombotic drugs. Hollopeter, Gunther; Jantzen, Hans-Michael; Vincent, Diana; Li, Georgia; England, Laura; Ramakrishnan, Vanitha; Yang, Ruey-Bing; Nurden, Paquita; Nurden, Alan; Julius, David; Conley, Pamela B. // Nature;1/11/2001, Vol. 409 Issue 6817, p202 

    Reports on a study of a platelet ADP receptor, designated P2Y, and provides evidence that a patient with a bleeding disorder has a defect in this gene. Role of platelets in maintaining normal haemostasis; How ADP mediates platelet aggregation through its actions with two G-protein-coupled...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics